Eduardo Cremonese Filippi-Chiela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Eduardo Cremonese Filippi-Chiela has a total of 289 co-authors. Here are the top co-authors by number of shared publications:
Guido Lenz
Programa de Pós‐Graduação Em Biologia Celular e Molecular, Universidade Federal do Rio Grande do Sul Porto Alegre Rio Grande do Sul Brazil
16 shared publications- Guido Lenz
Labsinal, Departamento de Biofísica, Universidade Federal Do Rio Grande Do Sul (UFRGS), Rua Bento Gonçalves, 9500, Prédio 43431 - Lab. 115, Porto Alegre, RS, 91501-970, Brazil.
13 shared publications - José Eduardo Vargas
Department of Cell Biology, Federal University of Paraná (UFPR), Curitiba 80060-000, PR, Brazil
6 shared publications Patrícia Luciana da Costa Lopez
Programa de Pós‐Graduação Ciências em Gastroenterologia e Hepatologia, Faculdade de Medicina Universidade Federal do Rio Grande do Sul (UFRGS) Porto Alegre Rio Grande do Sul Brazil
5 shared publicationsFabrício Figueiró
Departamento de Bioquímica Universidade Federal do Rio Grande do Sul Porto Alegre Brazil
4 shared publicationsMarcos Paulo Thomé
Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
4 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1286
Cellular senescence-related gene variants as risk factors for recurrent pregnancy loss
Background: Recurrent pregnancy loss (RPL) is characterized by two or more pregnancy losses. Despite its etiology encompassing known risk factors, over half of the cases remain idiopathic. In this sense, the search for molecular and cellular mechanisms that could be related to this condition is essential for explaining, at least in part, these cases. Cellular senescence (CS) is a state of cell cycle arrest that is present during reproduction and development; however, its impact on pregnancy remains unclear. Thus, our purpose was to evaluate the involvement of CS-related genes in the RPL context. Methods and Results: First, differential gene expression (DGE) of CDKN1A , CDKN2A , AKT1 , EP300 , TNF , and IFNG was assessed through a secondary analysis of publicly available datasets in the placenta and endometrium of RPL patients. Then, genetic variants (rs2395655, rs11515, rs1130233, rs20551, rs361525, and rs2430561, respectively) of these genes were evaluated in 107 women with RPL and 118 fertile controls. No difference in the expression of the genes assessed was found between the groups. On the other hand, the frequency of the CDKN1A allele A rs2395655 was more present in RPL patients than in fertile controls. In addition, a multiple comparison revealed two genotype combinations that were differently distributed between the groups (rs2395655 AG and rs11515 GG were more frequent in the RPL group; rs2395655 AG and rs11515 CG were more frequent in the controls), which might indicate them as associated with increased and decreased susceptibility factors, respectively, for RPL. Conclusion: Although our data are preliminary, we hypothesize that CS may represent a fraction of RPL cases.
- 28 July 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1286
Open AccessCellular senescence-related gene variants as risk factors for recurrent pregnancy loss
Background: Recurrent pregnancy loss (RPL) is characterized by two or more pregnancy losses. Despite its etiology encompassing known risk factors, over half of the cases remain idiopathic. In this sense, the search for molecular and cellular mechanisms that could be related to this condition is essential for explaining, at least in part, these cases. Cellular senescence (CS) is a state of cell cycle arrest that is present during reproduction and development; however, its impact on pregnancy remains unclear. Thus, our purpose was to evaluate the involvement of CS-related genes in the RPL context. Methods and Results: First, differential gene expression (DGE) of CDKN1A , CDKN2A , AKT1 , EP300 , TNF , and IFNG was assessed through a secondary analysis of publicly available datasets in the placenta and endometrium of RPL patients. Then, genetic variants (rs2395655, rs11515, rs1130233, rs20551, rs361525, and rs2430561, respectively) of these genes were evaluated in 107 women with RPL and 118 fertile controls. No difference in the expression of the genes assessed was found between the groups. On the other hand, the frequency of the CDKN1A allele A rs2395655 was more present in RPL patients than in fertile controls. In addition, a multiple comparison revealed two genotype combinations that were differently distributed between the groups (rs2395655 AG and rs11515 GG were more frequent in the RPL group; rs2395655 AG and rs11515 CG were more frequent in the controls), which might indicate them as associated with increased and decreased susceptibility factors, respectively, for RPL. Conclusion: Although our data are preliminary, we hypothesize that CS may represent a fraction of RPL cases.
- Open Access
- 10 April 2026
- Published by Wiley in Aging Cell
- Vol. 25 (4) , e70477
Morphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide
Several chemotherapeutics induce cancer cells to senescence, a persistent growth‐arrest state associated with poor cancer prognosis. Relevant features in cancer cell biology, such as phenotypic plasticity and intercellular variability, are poorly understood for senescent cells (SnCs). This study examined the morphofunctional heterogeneity and dynamics of glioblastoma cells induced to senescence by Temozolomide (TMZ), focusing on pro‐survival mechanisms, including autophagy and anti‐apoptotic proteins, and phenotypic plasticity. TMZ triggered a proliferative arrest with canonical features of senescence. Two distinct morphotypes emerged with different kinetics: extension‐rich (E‐state) cells, which were predominant early on, and flattened (F‐state) cells, which accumulated over time. These states were interchangeable, mostly from E‐state to F‐state, as revealed by single‐cell tracking. F‐state cells exhibited progressive enlargement of cellular and nuclear area, beyond extended survival, suggesting a more stable senescent phenotype despite lower p16 and autophagy levels than E‐state cells. Late autophagy inhibition using hydroxychloroquine broadly sensitized both morphotypes, reducing enlarged cells. Otherwise, early autophagy inhibition with 3‐methyladenine was not cytotoxic but led to E‐state accumulation over F‐state cells, suggesting an impact on morphometric dynamics. Beyond autophagy and p16, F‐state cells also expressed lower levels of anti‐apoptotic Bcl‐2 proteins, indicating differential activation of survival pathways. Notably, the senolytics dasatinib preferentially eliminated E‐state cells. These findings highlight the plasticity and heterogeneity of TMZ‐induced senescent glioblastoma cells and emphasize the need for selective senotherapeutic strategies aiming to attenuate the pro‐tumor effects exerted by SnCs on the tumor microenvironment.
- 10 April 2026
- Published by Wiley in Aging Cell
- Vol. 25 (4) , e70477
Open AccessMorphofunctional Heterogeneity and Plasticity of Glioblastoma Cells Induced to Senescence by Temozolomide
Several chemotherapeutics induce cancer cells to senescence, a persistent growth‐arrest state associated with poor cancer prognosis. Relevant features in cancer cell biology, such as phenotypic plasticity and intercellular variability, are poorly understood for senescent cells (SnCs). This study examined the morphofunctional heterogeneity and dynamics of glioblastoma cells induced to senescence by Temozolomide (TMZ), focusing on pro‐survival mechanisms, including autophagy and anti‐apoptotic proteins, and phenotypic plasticity. TMZ triggered a proliferative arrest with canonical features of senescence. Two distinct morphotypes emerged with different kinetics: extension‐rich (E‐state) cells, which were predominant early on, and flattened (F‐state) cells, which accumulated over time. These states were interchangeable, mostly from E‐state to F‐state, as revealed by single‐cell tracking. F‐state cells exhibited progressive enlargement of cellular and nuclear area, beyond extended survival, suggesting a more stable senescent phenotype despite lower p16 and autophagy levels than E‐state cells. Late autophagy inhibition using hydroxychloroquine broadly sensitized both morphotypes, reducing enlarged cells. Otherwise, early autophagy inhibition with 3‐methyladenine was not cytotoxic but led to E‐state accumulation over F‐state cells, suggesting an impact on morphometric dynamics. Beyond autophagy and p16, F‐state cells also expressed lower levels of anti‐apoptotic Bcl‐2 proteins, indicating differential activation of survival pathways. Notably, the senolytics dasatinib preferentially eliminated E‐state cells. These findings highlight the plasticity and heterogeneity of TMZ‐induced senescent glioblastoma cells and emphasize the need for selective senotherapeutic strategies aiming to attenuate the pro‐tumor effects exerted by SnCs on the tumor microenvironment.
- Open Access
- 18 November 2025
- Published by Wiley in The FEBS Journal
- Vol. 293 (14) , 4185-4205
Cellular Morphometric Analysis ( CellMorph )—a comprehensive imaging‐based tool for quantifying cellular phenotype heterogeneity and dynamics across biological processes
Understanding eukaryotic cell morphometry is fundamental to cell biology, as cells exhibit a broad range of sizes and shapes during processes such as senescence, cell death, mitosis, and migration. Dynamic changes in subcellular compartments and protein distribution also occur, impacting cytoplasmic and nuclear characteristics. Traditional measurement methods are often limited, highlighting the need for alternatives that comprehensively integrate data from both the cytosol and nuclei while tracking individual live cells over time. To address these limitations, we developed Cellular Morphometric Analysis (CellMorph), a novel tool designed to objectively assess multiple features of individual eukaryotic cells, including cell size, shape, cytosolic staining, and morphometry. CellMorph can analyze bright‐field and fluorescent images, accommodating both nonstained cells and those expressing fluorescent reporters or chromogenic labels. We validated the tool using various cellular models and specific staining protocols that target fundamental processes such as apoptosis, autophagy, and senescence. CellMorph captures the intricate heterogeneity within cell populations by providing a multidimensional perspective on individual cellular features and their differential responses to various stresses. This capability to track phenotypic changes over time makes CellMorph particularly valuable for studying dynamic cellular responses. Detailed morphometric data are essential for investigating cellular behavior in pathogenic processes and responses to stressors, including therapies or environmental changes. By integrating multiple parameters, CellMorph represents a significant advancement in cell biology, offering researchers a powerful tool to explore the complexities of cellular morphometry effectively.
- 18 November 2025
- Published by Wiley in The FEBS Journal
- Vol. 293 (14) , 4185-4205
Open AccessCellular Morphometric Analysis ( CellMorph )—a comprehensive imaging‐based tool for quantifying cellular phenotype heterogeneity and dynamics across biological processes
Understanding eukaryotic cell morphometry is fundamental to cell biology, as cells exhibit a broad range of sizes and shapes during processes such as senescence, cell death, mitosis, and migration. Dynamic changes in subcellular compartments and protein distribution also occur, impacting cytoplasmic and nuclear characteristics. Traditional measurement methods are often limited, highlighting the need for alternatives that comprehensively integrate data from both the cytosol and nuclei while tracking individual live cells over time. To address these limitations, we developed Cellular Morphometric Analysis (CellMorph), a novel tool designed to objectively assess multiple features of individual eukaryotic cells, including cell size, shape, cytosolic staining, and morphometry. CellMorph can analyze bright‐field and fluorescent images, accommodating both nonstained cells and those expressing fluorescent reporters or chromogenic labels. We validated the tool using various cellular models and specific staining protocols that target fundamental processes such as apoptosis, autophagy, and senescence. CellMorph captures the intricate heterogeneity within cell populations by providing a multidimensional perspective on individual cellular features and their differential responses to various stresses. This capability to track phenotypic changes over time makes CellMorph particularly valuable for studying dynamic cellular responses. Detailed morphometric data are essential for investigating cellular behavior in pathogenic processes and responses to stressors, including therapies or environmental changes. By integrating multiple parameters, CellMorph represents a significant advancement in cell biology, offering researchers a powerful tool to explore the complexities of cellular morphometry effectively.
- Open Access
Functional autophagy gene set signature and state classification reveal a link between autophagy induction, lysosomal activity, and poor prognosis in glioblastoma
Autophagy is an essential mechanism for maintaining cell homeostasis and, when dysregulated, is related to various pathologies. In cancer, it functions as a double-edged sword, either as a tumor suppressor or as a tumor promoter. Elevated GFP-LC3 puncta and increased levels of autophagy-related proteins, commonly interpreted as markers of high autophagic activity, are often associated with poor prognosis in tumors. However, current assessments of autophagy largely rely on isolated cellular and protein-level observations. While transcriptomic approaches offer broader insights, they often utilize large gene signatures without adequately accounting for the dynamic nature of autophagic flux. In this study, we propose a functional gene set signature for autophagy based on the rational mapping of flux stages, enabling the inference of distinct autophagy states. Using a supervised machine learning approach, we developed two indices - AutoIndex and LysoIndex - that effectively distinguish between cells treated with autophagy inducers and inhibitors. Applying this framework, we analyzed autophagy states across four cancer types, comparing tumor samples to matched normal tissues and evaluating their association with patient survival. Among these, glioblastoma (GBM) exhibited the strongest correlation between inferred autophagy states and clinical outcomes. GBM samples characterized by high LysoIndex and low AutoIndex—corresponding to a transcriptomic induction state—were linked to significantly poorer survival. Compared to lower-grade gliomas, GBM showed elevated lysosomal activity, which may contribute to its more aggressive behavior. Additionally, GBM cell lines treated with temozolomide displayed signatures consistent with autophagy induction, supporting our model’s predictive relevance. These results reinforce the understanding and monitoring of autophagy, and suggest that, in the case of GBM, its negative influence may represent a potential target for novel therapeutic interventions.
Open AccessFunctional autophagy gene set signature and state classification reveal a link between autophagy induction, lysosomal activity, and poor prognosis in glioblastoma
Autophagy is an essential mechanism for maintaining cell homeostasis and, when dysregulated, is related to various pathologies. In cancer, it functions as a double-edged sword, either as a tumor suppressor or as a tumor promoter. Elevated GFP-LC3 puncta and increased levels of autophagy-related proteins, commonly interpreted as markers of high autophagic activity, are often associated with poor prognosis in tumors. However, current assessments of autophagy largely rely on isolated cellular and protein-level observations. While transcriptomic approaches offer broader insights, they often utilize large gene signatures without adequately accounting for the dynamic nature of autophagic flux. In this study, we propose a functional gene set signature for autophagy based on the rational mapping of flux stages, enabling the inference of distinct autophagy states. Using a supervised machine learning approach, we developed two indices - AutoIndex and LysoIndex - that effectively distinguish between cells treated with autophagy inducers and inhibitors. Applying this framework, we analyzed autophagy states across four cancer types, comparing tumor samples to matched normal tissues and evaluating their association with patient survival. Among these, glioblastoma (GBM) exhibited the strongest correlation between inferred autophagy states and clinical outcomes. GBM samples characterized by high LysoIndex and low AutoIndex—corresponding to a transcriptomic induction state—were linked to significantly poorer survival. Compared to lower-grade gliomas, GBM showed elevated lysosomal activity, which may contribute to its more aggressive behavior. Additionally, GBM cell lines treated with temozolomide displayed signatures consistent with autophagy induction, supporting our model’s predictive relevance. These results reinforce the understanding and monitoring of autophagy, and suggest that, in the case of GBM, its negative influence may represent a potential target for novel therapeutic interventions.
- Open Access
- 4 August 2025
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 53 (04) , 935-952
The states of senescent cells
Senescent cells (SnCs) have typical changes in multiple features, such as increased cellular and nuclear size, morphofunctional alterations in organelles, and high secretory activity. The literature generally groups cellular changes and the non-proliferative character of SnCs into the autonomous senescent phenotype. In contrast, the influence of molecules and extracellular vesicles secreted by SnCs characterizes their non-autonomous phenotype. Unlike the detailed characterization of the structure of SnCs, the discussion regarding SnC states, which are characterized by the comprehensive integration of multiple features a cell harbors in a given moment, is still incipient. This review discusses the possible SnC states (SenStates) and their influence in pathophysiological contexts. We also discuss the main mechanisms and molecular players involved in the establishment and dynamics of these states, such as transcription factors, epigenetic marks, chromatin structure, and others. Finally, we discuss the biological relevance and potential clinical applications of SenStates, as well as open questions in the field.
- 4 August 2025
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 53 (04) , 935-952
Open AccessThe states of senescent cells
Senescent cells (SnCs) have typical changes in multiple features, such as increased cellular and nuclear size, morphofunctional alterations in organelles, and high secretory activity. The literature generally groups cellular changes and the non-proliferative character of SnCs into the autonomous senescent phenotype. In contrast, the influence of molecules and extracellular vesicles secreted by SnCs characterizes their non-autonomous phenotype. Unlike the detailed characterization of the structure of SnCs, the discussion regarding SnC states, which are characterized by the comprehensive integration of multiple features a cell harbors in a given moment, is still incipient. This review discusses the possible SnC states (SenStates) and their influence in pathophysiological contexts. We also discuss the main mechanisms and molecular players involved in the establishment and dynamics of these states, such as transcription factors, epigenetic marks, chromatin structure, and others. Finally, we discuss the biological relevance and potential clinical applications of SenStates, as well as open questions in the field.
- 20 March 2025
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 225, 112052
Molecular signatures of cellular senescence in cancer: a critical review of prognostic implications and therapeutic opportunities
- 20 March 2025
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 225, 112052
Molecular signatures of cellular senescence in cancer: a critical review of prognostic implications and therapeutic opportunities
- 9 May 2024
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 105 (3) , 100-113
Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis
Morphometry of striated muscle fibres is critical for monitoring muscle health and function. Here, we evaluated functional parameters of skeletal and cardiac striated muscle in two experimental models using the Morphometric Analysis of Muscle Fibre tool (MusMA). The collagen‐induced arthritis model was used to evaluate the function of skeletal striated muscle and the non‐alcoholic fatty liver disease model was used for cardiac striated muscle analysis. After euthanasia, we used haeamatoxylin and eosin stained sections of skeletal and cardiac muscle to perform muscle fibre segmentation and morphometric analysis. Morphometric analysis classified muscle fibres into six subpopulations: normal, regular hypertrophic, irregular hypertrophic, irregular, irregular atrophic and regular atrophic. The percentage of atrophic fibres was associated with lower walking speed (p = 0.009) and lower body weight (p = 0.026), respectively. Fibres categorized as normal were associated with maximum grip strength (p < 0.001) and higher march speed (p < 0.001). In the evaluation of cardiac striated muscle fibres, the percentage of normal cardiomyocytes negatively correlated with cardiovascular risk markers such as the presence of abdominal adipose tissue (p = .003), miR‐33a expression (p = .001) and the expression of miR‐126 (p = .042) Furthermore, the percentage of atrophic cardiomyocytes correlated significantly with the Castelli risk index II (p = .014). MusMA is a simple and objective tool that allows the screening of striated muscle fibre morphometry, which can complement the diagnosis of muscle diseases while providing functional and prognostic information in basic and clinical research.
- 9 May 2024
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 105 (3) , 100-113
Muscle fibre morphometric analysis (MusMA) correlates with muscle function and cardiovascular risk prognosis
Morphometry of striated muscle fibres is critical for monitoring muscle health and function. Here, we evaluated functional parameters of skeletal and cardiac striated muscle in two experimental models using the Morphometric Analysis of Muscle Fibre tool (MusMA). The collagen‐induced arthritis model was used to evaluate the function of skeletal striated muscle and the non‐alcoholic fatty liver disease model was used for cardiac striated muscle analysis. After euthanasia, we used haeamatoxylin and eosin stained sections of skeletal and cardiac muscle to perform muscle fibre segmentation and morphometric analysis. Morphometric analysis classified muscle fibres into six subpopulations: normal, regular hypertrophic, irregular hypertrophic, irregular, irregular atrophic and regular atrophic. The percentage of atrophic fibres was associated with lower walking speed (p = 0.009) and lower body weight (p = 0.026), respectively. Fibres categorized as normal were associated with maximum grip strength (p < 0.001) and higher march speed (p < 0.001). In the evaluation of cardiac striated muscle fibres, the percentage of normal cardiomyocytes negatively correlated with cardiovascular risk markers such as the presence of abdominal adipose tissue (p = .003), miR‐33a expression (p = .001) and the expression of miR‐126 (p = .042) Furthermore, the percentage of atrophic cardiomyocytes correlated significantly with the Castelli risk index II (p = .014). MusMA is a simple and objective tool that allows the screening of striated muscle fibre morphometry, which can complement the diagnosis of muscle diseases while providing functional and prognostic information in basic and clinical research.
- Open Access
- 30 March 2024
- Published by Wiley in Aging Cell
- Vol. 23 (4) , e14154
Subcellular structure, heterogeneity, and plasticity of senescent cells
Cellular senescence is a state of permanent growth arrest. It can be triggered by telomere shortening (replicative senescence) or prematurely induced by stresses such as DNA damage, oncogene overactivation, loss of tumor suppressor genes, oxidative stress, tissue factors, and others. Advances in techniques and experimental designs have provided new evidence about the biology of senescent cells (SnCs) and their importance in human health and disease. This review aims to describe the main aspects of SnCs phenotype focusing on alterations in subcellular compartments like plasma membrane, cytoskeleton, organelles, and nuclei. We also discuss the heterogeneity, dynamics, and plasticity of SnCs' phenotype, including the SASP, and pro‐survival mechanisms. We advance on the multiple layers of phenotypic heterogeneity of SnCs, such as the heterogeneity between inducers, tissues and within a population of SnCs, discussing the relevance of these aspects to human health and disease. We also raise the main challenges as well alternatives to overcome them. Ultimately, we present open questions and perspectives in understanding the phenotype of SnCs from the perspective of basic and applied questions.
- 30 March 2024
- Published by Wiley in Aging Cell
- Vol. 23 (4) , e14154
Open AccessSubcellular structure, heterogeneity, and plasticity of senescent cells
Cellular senescence is a state of permanent growth arrest. It can be triggered by telomere shortening (replicative senescence) or prematurely induced by stresses such as DNA damage, oncogene overactivation, loss of tumor suppressor genes, oxidative stress, tissue factors, and others. Advances in techniques and experimental designs have provided new evidence about the biology of senescent cells (SnCs) and their importance in human health and disease. This review aims to describe the main aspects of SnCs phenotype focusing on alterations in subcellular compartments like plasma membrane, cytoskeleton, organelles, and nuclei. We also discuss the heterogeneity, dynamics, and plasticity of SnCs' phenotype, including the SASP, and pro‐survival mechanisms. We advance on the multiple layers of phenotypic heterogeneity of SnCs, such as the heterogeneity between inducers, tissues and within a population of SnCs, discussing the relevance of these aspects to human health and disease. We also raise the main challenges as well alternatives to overcome them. Ultimately, we present open questions and perspectives in understanding the phenotype of SnCs from the perspective of basic and applied questions.
- 15 January 2024
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 125 (2)
The rational modulation of autophagy sensitizes colorectal cancer cells to 5‐fluouracil and oxaliplatin
Colorectal cancer (CRC) is the third most common and deadliest cancer globally. Regimens using 5‐fluorouracil (5FU) and Oxaliplatin (OXA) are the first‐line treatment for CRC, but tumor recurrence is frequent. It is plausible to hypothesize that differential cellular responses are triggered after treatments depending on the genetic background of CRC cells and that the rational modulation of cell tolerance mechanisms like autophagy may reduce the regrowth of CRC cells. This study proposes investigating the cellular mechanisms triggered by CRC cells exposed to 5FU and OXA using a preclinical experimental design mimicking one cycle of the clinical regimen (i.e., 48 h of treatment repeated every 2 weeks). To test this, we treated CRC human cell lines HCT116 and HT29 with the 5FU and OXA, combined or not, for 48 h, followed by analysis for two additional weeks. Compared to single‐drug treatments, the co‐treatment reduced tumor cell regrowth, clonogenicity and stemness, phenotypes associated with tumor aggressiveness and poor prognosis in clinics. This effect was exerted by the induction of apoptosis and senescence only in the co‐treatment. However, a week after treatment, cells that tolerated the treatment had high levels of autophagy features and restored the proliferative phenotype, resembling tumor recurrence. The pharmacologic suppression of early autophagy during its peak of occurrence, but not concomitant with chemotherapeutics, strongly reduced cell regrowth. Overall, our experimental model provides new insights into the cellular mechanisms that underlie the response and tolerance of CRC cells to 5FU and OXA, suggesting optimized, time‐specific autophagy inhibition as a new avenue for improving the efficacy of current treatments.
- 15 January 2024
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 125 (2)
The rational modulation of autophagy sensitizes colorectal cancer cells to 5‐fluouracil and oxaliplatin
Colorectal cancer (CRC) is the third most common and deadliest cancer globally. Regimens using 5‐fluorouracil (5FU) and Oxaliplatin (OXA) are the first‐line treatment for CRC, but tumor recurrence is frequent. It is plausible to hypothesize that differential cellular responses are triggered after treatments depending on the genetic background of CRC cells and that the rational modulation of cell tolerance mechanisms like autophagy may reduce the regrowth of CRC cells. This study proposes investigating the cellular mechanisms triggered by CRC cells exposed to 5FU and OXA using a preclinical experimental design mimicking one cycle of the clinical regimen (i.e., 48 h of treatment repeated every 2 weeks). To test this, we treated CRC human cell lines HCT116 and HT29 with the 5FU and OXA, combined or not, for 48 h, followed by analysis for two additional weeks. Compared to single‐drug treatments, the co‐treatment reduced tumor cell regrowth, clonogenicity and stemness, phenotypes associated with tumor aggressiveness and poor prognosis in clinics. This effect was exerted by the induction of apoptosis and senescence only in the co‐treatment. However, a week after treatment, cells that tolerated the treatment had high levels of autophagy features and restored the proliferative phenotype, resembling tumor recurrence. The pharmacologic suppression of early autophagy during its peak of occurrence, but not concomitant with chemotherapeutics, strongly reduced cell regrowth. Overall, our experimental model provides new insights into the cellular mechanisms that underlie the response and tolerance of CRC cells to 5FU and OXA, suggesting optimized, time‐specific autophagy inhibition as a new avenue for improving the efficacy of current treatments.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13286
Guarana (Paullinia cupana) as a potential tool for mesenchymal stromal cells priming in regenerative medicine
Mesenchymal stromal cells (MSCs) have therapeutic potential due to their abilities of differentiation, immunomodulation, and migration to injured tissues, potentiating such effects when cells are activated. Guarana (Paullinia cupana) is a tropical plant species found in South America that is known for its antioxidant, stimulant, and cicatricial effects. The guarana extract is composed of many substances and caffeine is the main component. The objective was to evaluate the effects of guarana and caffeine on MSCs. After the initial characterization, MSCs were treated with Paullinia cupana (10, 100, and 1000 μg/mL) or caffeine (0.4, 4, and 40 μg/mL) for 24 h. MSCs treatment with 1000 μg/mL guarana increased cell polarity, viability, cell migration to chemoattractant, antioxidant potential, and liberation of extracellular vesicles (EVs), while it reduced the levels of autophagy. MSCs treated with 100 and 1000 μg/mL guarana or 40 μg/mL caffeine showed a decrease of cell proliferation. No treatment affected the cellular area and cell cycle of MSCs. The study shows in vitro evidence that guarana could be a promising alternative for activating MSCs to promote better cellular products for future clinical therapies.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 57, e13286
Open AccessGuarana (Paullinia cupana) as a potential tool for mesenchymal stromal cells priming in regenerative medicine
Mesenchymal stromal cells (MSCs) have therapeutic potential due to their abilities of differentiation, immunomodulation, and migration to injured tissues, potentiating such effects when cells are activated. Guarana (Paullinia cupana) is a tropical plant species found in South America that is known for its antioxidant, stimulant, and cicatricial effects. The guarana extract is composed of many substances and caffeine is the main component. The objective was to evaluate the effects of guarana and caffeine on MSCs. After the initial characterization, MSCs were treated with Paullinia cupana (10, 100, and 1000 μg/mL) or caffeine (0.4, 4, and 40 μg/mL) for 24 h. MSCs treatment with 1000 μg/mL guarana increased cell polarity, viability, cell migration to chemoattractant, antioxidant potential, and liberation of extracellular vesicles (EVs), while it reduced the levels of autophagy. MSCs treated with 100 and 1000 μg/mL guarana or 40 μg/mL caffeine showed a decrease of cell proliferation. No treatment affected the cellular area and cell cycle of MSCs. The study shows in vitro evidence that guarana could be a promising alternative for activating MSCs to promote better cellular products for future clinical therapies.